Different Substrates of Non-Sustained Ventricular Tachycardia in Post-infarction Patients With and Without Left Ventricular Dilatation

Journal of Cardiac Failure

Volumn 16, Issue 1, 2010, Pages 61-68

  Di Bella, Gianluca ^a,b   Passino, Claudio ^a,c   Aquaro, Giovanni Donato ^a   Rovai, Daniele ^a   Strata, Elisabetta ^a   Arrigo, Francesco ^b   Emdin, Michele ^a   Lombardi, Massimo ^a   Pingitore, Alessandro ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Cardiac magnetic resonance; myocardial infarction; scar tissue

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOBUTROL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ELECTROCARDIOGRAM; FEMALE; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; LEFT VENTRICULAR DILATATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONSUSTAINED VENTRICULAR TACHYCARDIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCAR; SCINTIGRAPHY; STRESS ECHOCARDIOGRAPHY; COMPARATIVE STUDY; COMPLICATION; ELECTROCARDIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; TACHYCARDIA, VENTRICULAR;

AGED; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 73049118008     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.09.001     Document Type: Article

References (46)

1. Moss A.J., Zareba W., Hall W.J., Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Reynolds M.R., and Josephson M.E. MADIT II (Second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation 108 (2003) 1779-1783
3. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 (2001) 1473-1482
4. Glass L., and Lerma C. Risk stratification for arrhythmic sudden cardiac death. Heart Rhythm 3 (2006) 1497-1501
5. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
6. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes III N.A., Freedman R.A., Gettes L.S., et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2 (2008) e1-e62
7. Huikuri H.V., Mäkikallio T.H., Raatikainen M.J., Perkiömäki J., Castellanos A., and Myerburg R.J. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108 (2003) 110-115
8. St John Sutton M., Lee D., Rouleau J.L., Goldman S., Plappert T., Braunwald E., et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 107 (2003) 2577-2582
9. Podrid P., Fogel R., and Fuchs T. Ventricular arrhythmia in congestive heart failure. Am J Cardiol 69 (1992) 82G-96G
10. Singh S.N., Fisher S.G., Carson P.E., and Fletcher R.D. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 32 (1998) 942-947
11. de Sousa M.R., Morillo C.A., Rabelo F.T., Nogueira Filho A.M., and Ribeiro A.L. Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis. Eur J Heart Fail 10 (2008) 1007-1014
12. Buxton A.E., Lee K.L., Hafley G.E., Pires L.A., Fisher J.D., Gold M.R., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50 (2007) 1150-1157
13. Grayburn P.A., Appleton C.P., DeMaria A.N., Greenberg B., Lowes B., Oh J., Plehn J.F., et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 45 (2005) 1064-1071
14. Wong S.P., French J.K., Lydon A.M., Manda S.O., Gao W., Ashton N.G., et al. Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction. Am J Cardiol 94 (2004) 1270-1275
15. Pennell D.J., Sechtem U.P., Higgins C.B., Manning W.J., Pohost G.M., Rademakers F.E., et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 25 (2004) 1940-1965
16. Yan A.T., Shayne A.J., Brown K.A., Gupta S.N., Chan C.W., Luu T.M., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post myocardial infarction mortality. Circulation 114 (2006) 32-39
17. Schmidt A., Azevedo C.F., Cheng A., Gupta S.N., Bluemke D.A., Foo T.K., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006-2014
18. Alfakih K., Plein S., Thiele H., Jones T., Ridgway J.P., and Sivananthan M.U. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17 (2003) 323-329
19. Hees P.S., Fleg J.L., Lakatta E.G., and Shapiro E.P. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol 90 (2002) 1231-1236
20. Watzinger N., Lund G.K., Higgins C.B., Wendland M.F., Weinmann H.J., and Saeed M. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging 16 (2002) 633-640
21. Pandian N.G., Skorton D.J., Collins S.M., Falsetti H.L., Burke E.R., and Kerber R.E. Heterogeneity of left ventricular segmental wall thickening and excursion in 2-dimensional echocardiograms of normal human subjects. Am J Cardiol 51 (1983) 1667-1673
22. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
23. St John Sutton M., Pfeffer M.A., Plappert T., Rouleau J.L., Moyé L.A., Dagenais G.R., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after myocardial infarction: the protective effects of captopril. Circulation 89 (1994) 68-75
24. Gaudron P., Kugler I., Hu K., Bauer W., Eilles C., and Ertl G. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol 38 (2001) 33-40
25. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96 (1997) 4065-4082
26. Janicki J.S., and Brower G.L. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 8 Suppl (2002) S319-S325
27. Dillon S.M., Allessie M.A., Ursell P.C., and Wit A.L. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 63 (1988) 182-206
28. Pogwizd S.M., Hoyt R.H., Saffitz J.E., Corr P.B., Cox J.L., and Cain M.E. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 86 (1992) 1872-1887
29. Richards D.A., Blake G.J., Spear J.F., and Moore E.N. Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. Circulation 69 (1984) 369-381
30. Cardinal R., Vermeulen M., Shenasa M., Roberge F., Page P., Hélie F., et al. Anisotropic conduction and functional dissociation of ischemic tissue during reentrant ventricular tachycardia in canine myocardial infarction. Circulation 77 (1988) 1162-1176
31. Bolick D., Hackel D., Reimer K., and Ideker R. Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation 74 (1986) 1266-1279
32. Bello D., Fieno D.S., Kim R.J., Pereles F.S., Passman R., Song G., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
33. Nazarian S., Bluemke D.A., Lardo A.C., Zviman M.M., Watkins S.P., Dickfeld T.L., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
34. Pogwizd S.M., Hoyt R.H., Saffitz J.E., Corr P.B., Cox J.L., and Cain M.E. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 86 (1992) 1872-1887
35. de Bakker J.M., van Capelle F.J., Janse M.J., Tasseron S., Vermeulen J.T., de Jonge N., et al. Slow conduction in the infarcted human heart: 'zigzag' course of activation. Circulation 88 (1993) 915-926
36. de Bakker J.M., van Capelle F.J., Janse M.J., Wilde A.A., Coronel R., Becker A.E., et al. Reentry as a cause of VT in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 77 (1988) 589-606
37. Buxton A.E., Fisher J.D., Josephson M.E., Lee K.L., Pryor D.B., Prystowsky E.N., et al. Prevention of sudden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Prog Cardiovasc Dis 36 (1993) 215-226
38. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 (2006) 247-346
39. Prystowsky E.N. Screening and therapy for patients with nonsustained ventricular tachycardia. Am J Cardiol 86 (2000) 34K-39K
40. Westenberg J.J., van der Geest R.J., Lamb H.J., Versteegh M.I., Braun J., Doornbos J., et al. MRI to evaluate left atrial and ventricular reverse remodeling after restrictive mitral annuloplasty in dilated cardiomyopathy. Circulation 112 (2005) I437-I442
41. Rajappan K., Bellenger N.G., Anderson L., and Pennell D.J. The role of cardiovascular magnetic resonance in heart failure. Eur J Heart Fail 2 (2000) 241-252
42. Singh S.N., Fisher S.G., Carson P.E., and Fletcher R.D. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 32 (1998) 942-947
43. Teerlink J.R., Jalaluddin M., Anderson S., Kukin M.L., Eichhorn E.J., Francis G., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 101 (2000) 40-46
44. Nakamura Y., Ebihara Y., Toyama M., and Ogawa S. A predictive value of ventricular tachycardia detected by long-term electrocardiography for sudden cardiac death. Kokyu To Junkan 39 (1991) 1235-1239
45. Wichterle D., Simek J., Camm J., and Malik M. Predictive characteristics of Holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. Pacing Clin Electrophysiol 28 (2005) S182-S186
46. Anderson K.P. Risk assessment for defibrillator therapy: Il Trittico. J Am Coll Cardiol 50 (2007) 1158-1160